Articles citing this paper
Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase
Karla L. Seaman
A B H , Frank M. Sanfilippo C , Max K. Bulsara D , Tom Brett E , Anna Kemp-Casey F G , Elizabeth E. Roughead F , Caroline Bulsara D and David B. Preen G
A School of Health Sciences, University of Notre Dame, Fremantle, 19 Mouat Street, P.O. Box 1225, WA 6959, Australia.
B School of Nursing and Midwifery, Edith Cowan University, Building 21, 270 Joondalup Drive, Joondalup, WA 6027, Australia.
C Cardiovascular Research Group, School of Population and Global Health, University of Western Australia, M431, 35 Stirling Highway, Perth, WA 6009, Australia. Email: frank.sanfilippo@uwa.edu.au
D Institute for Health Research, University of Notre Dame, Fremantle, 19 Mouat Street, P.O. Box 1225, WA 6959, Australia. Email: max.bulsara@nd.edu.au; caroline.bulsara@nd.edu.au
E School of Medicine, University of Notre Dame, Fremantle, 19 Mouat Street, P.O. Box 1225, WA 6959, Australia. Email: tom.brett@nd.edu.au
F Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia. Email: anna.kemp@uwa.edu.au; Libby.Roughead@unisa.edu.au
G Center of Health Services Research, School of Population and Global Health, M431, 35 Stirling Highway, University of Western Australia, Crawley, WA 6009, Australia. Email: david.preen@uwa.edu.au
H Corresponding author. Email: karla.seaman1@my.nd.edu.au
Australian Health Review 44(3) 377-384 https://doi.org/10.1071/AH19069
Submitted: 20 March 2019 Accepted: 5 December 2019 Published: 11 May 2020
